NHS Framework Agreement for the supply of Ranibizumab for the NHS in England

A Tender Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
1 year
Value
£120M
Sector
HEALTH
Published
09 Jan 2023
Delivery
01 Apr 2023 to 31 Mar 2024
Deadline
10 Feb 2023 00:00

Concepts

Location

Yorkshire and the Humber: NHS England

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.Anti Veg-F medicines are currently used in the treatment of: a. neovascular (wet) age-related macular degeneration (AMD);b. visual impairment due to diabetic macular oedema (DME/DMO);c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); andd. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).

Renewal Options

An option to extend for a further period of 12 months. i.e. the total possible framework agreement duration is 24 months.

CPV Codes

  • 33690000 - Various medicinal products
  • 33600000 - Pharmaceutical products

Indicators

  • This is a recurring contract.
  • Renewals are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains